Section of Pediatric and Congenital Cardiac Surgery, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, School of Medicine, Padova, Italy.
Section of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, School of Medicine, Padova, Italy.
Eur J Cardiothorac Surg. 2017 Oct 1;52(4):789-797. doi: 10.1093/ejcts/ezx245.
Our goal was to evaluate the early and late results of the surgical management of congenital supravalvular aortic stenosis (SVAS).
We performed a retrospective, multicentre study using data from the European Congenital Heart Surgeons Association. Exclusion criteria were age >18 years, operation before 1990 and redo supravalvular aortic stenosis operations. Multivariate Cox regression analysis was performed to detect independent predictors of adverse events.
Of a total of 301 patients (male/female = 194/107; median age 3.9 years, range 13 days-17.9 years), 17.6% had a prior surgical or interventional procedure. Pulmonary artery stenosis was present in 41.5% and coronary anomalies in 13.6%. The operation consisted of a single patch repair in 36.7%, a pantaloon-shaped patch in 36.7%, a 3-patch technique in 14.3% and other techniques in 11.7%. Postoperative complications occurred in 14.9%, and the early mortality rate was 5%. At a median follow-up of 13 years (interquartile range 3.5-7.8; follow-up completed 79.1%), there were 10 late deaths (4.2%). A surgical reoperation or an interventional cardiology procedure occurred in 12.6% and 7.2%, respectively. No significant differences in outcomes between the techniques were found. Age at repair <12 months and pulmonary artery stenosis were associated with an increased risk of early (P = 0.0001) and overall mortality (P = 0.025), respectively. Having an operation after 2005 and co-existing pulmonary artery stenosis were significant predictors of late reintervention (P = 0.0110 and P = 0.001, respectively).
Surgical repair of congenital stenosis is an effective procedure with acceptable surgical risk and good late survival, but late morbidity is not negligible, especially in infants and when associated pulmonary artery stenosis is present.
评估先天性主动脉瓣上狭窄(SVAS)的手术治疗的早期和晚期结果。
我们使用欧洲先天性心脏外科医师协会的数据进行了回顾性、多中心研究。排除标准为年龄>18 岁、1990 年前手术以及再行主动脉瓣上狭窄手术。采用多变量 Cox 回归分析检测不良事件的独立预测因子。
在总共 301 例患者(男/女=194/107;中位年龄 3.9 岁,范围 13 天-17.9 岁)中,17.6%的患者既往有手术或介入治疗史。41.5%的患者合并肺动脉狭窄,13.6%的患者合并冠状动脉异常。手术方式为单一补片修补 36.7%、裤形补片 36.7%、3 补片技术 14.3%和其他技术 11.7%。术后并发症发生率为 14.9%,早期死亡率为 5%。中位随访 13 年(四分位间距 3.5-7.8;随访完成 79.1%)时,有 10 例晚期死亡(4.2%)。再次手术或介入心脏病学治疗分别发生在 12.6%和 7.2%的患者中。未发现技术之间的结果有显著差异。修复时年龄<12 个月和肺动脉狭窄与早期(P=0.0001)和总死亡率(P=0.025)增加相关。2005 年后手术和并存肺动脉狭窄是晚期再介入的显著预测因子(P=0.0110 和 P=0.001)。
先天性狭窄的手术修复是一种有效的治疗方法,手术风险可接受,晚期生存率良好,但晚期发病率不容忽视,尤其是在婴儿和存在肺动脉狭窄时。